28 29 30 2 Summary 31 BLM or WRN helicases function with the DNA2 helicase-nuclease to resect DNA double-32 strand breaks and initiate homologous recombination. Upon DNA unwinding by BLM/WRN, 33
in human TK6 cells (Hoa et al., 2015a). Finally, single molecule analysis of DNA resection 140 tracks showed that CtIP contributes to fast resection at long distances from the DNA end 141 (Cruz-Garcia et al., 2014), which disagrees with the expected range of the MRN-dependent 142 short-range resection. Together, these reports suggest that CtIP may promote long-range 143 DNA end resection by an unknown mechanism. In accord, CtIP was shown to physically in-144 teract with and promote DNA unwinding by the BLM helicase, as well as to modestly stimu-145 late DNA degradation by the DNA2 nuclease . Using ensemble and single 146 molecule biochemistry, we show here that phosphorylated CtIP dramatically stimulates the 147 6 motor activity of DNA2. This accelerates degradation of RPA-coated ssDNA by DNA2, show-148 ing the need for the motor activity of DNA2 to facilitate resection. Our results show that 149
CtIP is thus a co-factor not only of MRE11, but also of DNA2, and demonstrate that the do-150 mains of CtIP required for the stimulation of MRN and DNA2 are physically separate. Our 151 data support a model where CtIP first activates the MRE11 nuclease, and then helps couple 152 short-range resection with the downstream long-range step by promoting DNA2. These re-153 sults explain the dramatic DNA end resection defect observed in CtIP-depleted human cells. To study the effect of CtIP on long-range DNA end resection pathways in a defined system, 164
we expressed and purified phosphorylated human CtIP (pCtIP) in the presence of phospha-165 tase inhibitors, DNA2, BLM, WRN and EXO1 (Fig. S1C−S1G) in Sf9 cells. Recombinant pCtIP 166 did not promote DNA degradation by EXO1 ( Fig. S1H ), but stimulated DNA end resection by 167 BLM-DNA2-RPA (Fig. S1I−S1K), as well as by WRN-DNA2-RPA (Fig. 1A , compare lanes 6 and 168 9). To understand the stimulation of resection by pCtIP in detail, we next investigated its ef-169 fect on the activities of BLM/WRN and DNA2 individually. pCtIP stimulated DNA unwinding 170 by BLM ~2-fold ( Fig. S1L ), as well as to a similar extent the nuclease of DNA2 on oligonucleo-171 tide-based substrates ( Fig. 1B−1C) , as noted previously . In contrast, pCtIP 172 did not significantly promote DNA unwinding by WRN (Fig. S1M ). The strongest stimulatory 173 effect by pCtIP was observed when we assayed DNA unwinding by nuclease-dead DNA2 174 D277A ( Fig. 1D−1E) . With pCtIP, 0.25 nM DNA2 D277A unwound more than 50% of the Y-175 structured DNA substrate, which was more than that unwound by 30 nM DNA2 D277A with-176 out pCtIP, corresponding to >10-fold stimulation ( Fig. 1D−1E ). Recombinant pCtIP thus pre-177 dominantly promotes the motor activity of DNA2. 178 179
CtIP dramatically promotes long-range ssDNA degradation by DNA2 180
To define the function of pCtIP in regulating DNA2 in a simple system, we next used an assay 181 that monitors 5'→3' degradation of 3' end-labeled fragments of ssDNA by wild type DNA2. 182
The use of ssDNA bypasses the requirement for BLM or WRN helicase. Without pCtIP, the 183 degradation of ssDNA by DNA2 was slow (Fig 2A, lanes 3-7) , and was strikingly ~10-fold 184 stimulated when pCtIP was included in the reactions (Fig 2A, lanes 9-13, Fig. 2B ). While 185 pCtIP appears to accelerate ssDNA degradation by DNA2, it did not change the 5'→3' polar-186 ity of DNA degradation in the presence of RPA ( Fig. S2A−S2B) . Likewise, pCtIP did not allow 187 phosphorylation sites, and finally a conserved C-terminal domain that is required to activate 252 MRN, has a secondary DNA binding site and is likewise subject to phosphorylation ( for the stimulation of DNA2, we designed pCtIP variants lacking stretches of amino acids 259 from the internal region such as pCtIP D1 (lacking residues 350-600 including the DNA-bind-260 ing region) and pCtIP D2 (lacking residues 165-790 comprising the entire region between the 261 tetramerization domain and the Sae2-like C-terminal domain). As wild type full-length pCtIP, 262 these internally truncated variants were expressed in Sf9 cells and purified in the presence 263 of phosphatase inhibitors to preserve phosphorylation. We observed that pCtIP D1, but not 264 pCtIP D2, was fully proficient in stimulating DNA2 ( Fig. 5B−5C, Fig. S5A ). This indicated that 265 the region in pCtIP between residues 350 and 600 containing the DNA binding domain is dis-266 pensable for the stimulation of DNA2, and the stimulatory activity is dependent on a region 267 upstream or downstream of these residues. We also prepared the C-terminal domain of 268 pCtIP alone (pCtIP D3, containing residues 790-897), and a mutant lacking this C-terminal 269 domain (pCtIP D4) ( To further map the CtIP region required to stimulate DNA2, we expressed various por-276 tions of the central CtIP domain in E. coli (Fig. 5D ). We prepared the central region corre-277 sponding to residues 350-600, as well as fragments containing additionally the upstream 278 and downstream regions from the wider central domain ( Fig. 5D ). We observed that CtIP F3 279 fragment, containing residues 350-790, was capable to promote DNA2 (Fig. 5E ). This indi-280 cated that the CtIP region downstream of residue 600 was required for DNA2 stimulation. 281
We note that this domain is lacking in yeast Sae2, and our result is thus in agreement with 282 the observation that yeast Sae2 does not promote yeast or human DNA2 ( Fig. 3G ). We ob-283 served that a high concentration of the F3 fragment compared to pCtIP variants expressed 284 in insect cells was needed to observe DNA2 stimulation (compare Fig. 5C and Fig. 5E ), indi-285 cating a lower stimulatory capacity of the polypeptide expressed in E. coli compared to vari-286 ants prepared in Sf9 cells. 287
To narrow down the stimulatory region in pCtIP even further, we expressed in Sf9 cells 288 and purified an additional series of internal pCtIP truncations lacking also residues down-289 stream of position 600 ( Fig. 5F, Fig. S5G ). We observed that pCtIP D1B fragment (lacking res-290 idues 350-690) was fully proficient in stimulating DNA2, but additional shortening of this 291 mutant by 50 residues (pCtIP D1C, lacking residues 350-740) entirely eliminated this capac-292 Fig. S5H ). In contrast, the pCtIP D1C construct was fully proficient in stimulat-293 ing the endonuclease of MRN ( Fig. 5I-J) . These experiments established that the pCtIP re-294 gion immediately downstream of residue 690 is required for the stimulation of the DNA2 295 motor activity, while it is dispensable for the stimulation of MRN. 296
We also note that pCtIP NA/HA, which was described to lack intrinsic nuclease activity 297 functions. The NA/HA mutations may thus not strictly reflect an intrinsic nuclease defect. 303
Finally, DNA2 nuclease and helicase-dead (DNA2 D277A/K654R) had no effect on the endo-304 nuclease activity of the MRN-pCtIP complex ( Fig. S5O ). Together, these results establish that 305 pCtIP promotes MRN and DNA2 via distinct domains that are fully separable, and map the 306 minimal region required for the stimulation of DNA2 between residues 690 and 790 of 307 pCtIP. 308 309 pCtIP phosphorylation facilitates its capacity to promote DNA2 310 and T847A ( Fig. S6H ). None of these mutations eliminated the capacity of pCtIP to promote 329 DNA2 ( Fig. S6I ), indicating that these phosphorylation sites are either functionally redun-330 dant, or that phosphorylation on residues other than those analyzed is important for the ob-331 served activity. 332
We conclude that pCtIP phosphorylation clearly facilitates the stimulation of DNA2. This 333 is likely caused, at least in part, indirectly by preventing pCtIP aggregation. Furthermore, 334
while CtIP tetramerization is essential to stimulate MRN ( both short-range and long-range resection nucleases ( Fig. 7A ). We propose that coupling of 346 both resection steps by CtIP allows to better coordinate and regulate DNA end resection. 347
The CtIP domains required to promote MRE11 and DNA2 are at least partially separate. 348
We found that the very N-terminal and C-terminal domains of CtIP, while being required to 349 promote MRE11, are largely dispensable to regulate DNA2 (Fig. 7B ). Instead, we identified a 350 region in the central domain of pCtIP between residues 690 and 790 that is essential to 351 stimulate DNA2, but dispensable for stimulating MRN (Fig. 7B ). The central domain of CtIP is 352 lacking in homologues of low eukaryotes such as in S. cerevisiae Sae2. In accord, we failed to 353 observe stimulation of yeast Dna2 by yeast Sae2. Therefore, while the regulation of MRE11 354 by CtIP is conserved in evolution, the regulation of DNA2 appears to be restricted to higher Our data indicate that CtIP primarily functions to stimulate the ATPase-dependent ssDNA 380 translocase activity of DNA2. While DNA2 is primarily active as a nuclease, the function of its 381 helicase domain remained somewhat elusive. We previously reported that the helicase ac- Finally, we demonstrate that phosphorylation of pCtIP facilitates its capacity to promote 403 DNA2. Therefore, similarly to the interplay with MRE11, phosphorylation represents a key 404 regulatory mechanism that keeps the DNA2 activity in check. Together, this allows resection 405 only in the S-G2 phases of the cell cycle and upon DNA damage, which limits illegitimate re- Biolabs) and Ni-NTA (Qiagen) resins with the same buffers and procedure described for wild-441 type CtIP and its variants expressed in Sf9 cells (Anand et al., 2016) . Human and yeast RPA 442 were expressed in E. coli and purified using ÄKTA pure (GE Healthcare) with HiTrap Blue HP, 443
HiTrap desalting and HiTrap Q chromatography columns (all GE Healthcare)(Anand et al., 444 2018). EXO1-FLAG was expressed in Sf9 cells and purified as described in detail in supple-445 mentary information. The sequence of all primers used for PCR and cloning in this study is 446 listed in Supplementary Table 1 indicated to saturate all ssDNA. Additional recombinant proteins were then added on ice 485 and the reactions were incubated at 37°C as indicated to perform kinetic experiments. Reac-486 tions were stopped by adding 5 µl of 2% stop solution (150 mM EDTA, 2% sodium dodecyl 487 sulfate, 30% glycerol, bromophenol blue) and 1 µl of proteinase K (Sigma) and incubated at 488 37°C for 10 min. Samples were analyzed by 1% agarose gel electrophoresis. Gels were dried 489 on DE81 chromatography paper (Whatman), exposed to storage phosphor screens (GE 490 Healthcare) and scanned by a Typhoon 9500 phosphorimager (GE Healthcare). Analysis of 491 ssDNA degradation was performed with 0.15 nM (in molecules) 3'-labeled λ DNA/HindIII 492 fragments that were heat-denatured for 5 min at 95°C before adding to the reaction mix-493 ture. Differently from above, the reaction buffer contained 3 mM magnesium acetate, no 494 salt, and, unless indicated otherwise, reactions were incubated at 37°C for 8 min. When 495 yeast proteins were used, the experiment was performed at 25°C for 1 min and yeast RPA 496 was added in each reaction. Nuclease assays with 32 P-labeled Y-shaped DNA substrate (0.1 497 nM in molecules) were carried out in a similar buffer containing 100 mM NaCl at 37°C and 498 the reactions were stopped by adding 0.5 µl ethylenediaminetetraacetic (0.5 M EDTA) and 1 499 μl Proteinase K, and incubated at 50°C for 30 min. An equal amount of formamide dye (95% 500
[v/v] formamide, 20 mM EDTA, bromophenol blue) was added and samples were heated at 501 95°C for 4 min and separated on 15% denaturing polyacrylamide gels (ratio acryla-502 mide:bisacrylamide 19:1, Biorad). After fixing in a solution containing 40% methanol, 10% 503 acetic acid and 5% glycerol for 30 min the gels were dried on 3 mm paper (Whatman) and 504 analyzed as described above. Endonuclease assays with MRN and phosphorylated CtIP (15 505 µl volume) were performed in nuclease buffer containing 25 mM Tris-HCl pH 7.5, 5 mM 506 magnesium acetate, 1 mM manganese acetate, 1 mM ATP, 1 mM DTT, 0.25 mg/ml BSA, 1 507 mM phosphoenolpyruvate, 80 U/ml pyruvate kinase, and 1 nM oligonucleotide-based DNA 508 substrate (in molecules). Biotinylated DNA ends were blocked by adding 15 nM streptavidin 509 and incubating the samples 5 min at room temperature. Samples were then processed and 510 In a subsequent ligation step the oligomer was ligated at its 3ꞌ end inside the gap. Also 600 bp 559 long digoxigenin-and biotin-modified handles were ligated with corresponding sticky ends to 560 the termini of the 6.6 kbp fragment. lipore], 0.5 mM PMSF) and incubated at 4°C for 10 min. Glycerol was added to a final con-604 centration of 25%, NaCl was added to a final concentration of 305 mM and the solution was 605 incubated at 4°C for 30 min. The mixture was centrifuged at 55000 g at 4°C for 30 min. The 606 soluble extract was incubated with M2 anti FLAG affinity resin (Sigma) at 4°C for 30 minutes. 607 FLAG resin was washed with TBS wash buffer (20 mM Tris-HCl pH 7.5, 0.5 mM β-mercap-608 toethanol, 0.5 mM PMSF, 1 mM EDTA, 1:1000 protease inhibitor cocktail, 6.7 µg/ml leupep-609 tine, 10% glycerol, 150 mM NaCl) supplemented with 0.1 % NP40. The last wash was per-610 formed with the same buffer but without NP40. Protein was eluted using TBS wash buffer 611 without NP40 supplemented with 200 µg/ml 3XFLAG peptide (Sigma). Peak fractions, as es-612 timated by the Bradford method, were pooled and diluted by adding 1.5 volumes of dilution 613 buffer (50 mM Tris-HCl pH 7.5, 5 mM β-mercaptoethanol, 0.5 mM PMSF, 6.7 µg/ml leupep-614 tine, 10% glycerol). The diluted fractions were loaded on HiTrap SP HP cation exchange 615 chromatography column (GE Healthcare) (0.8 ml/min) and washed with buffer A (50 mM 616
Tris-HCl pH 7.5, 5 mM β-mercaptoethanol, 10% glycerol, 75 mM NaCl). Proteins were eluted 617 using a 5 ml gradient of 75 mM to 1 M NaCl in 0.8 ml fractions. Peak fractions were pooled, 618 snap-frozen in liquid nitrogen and stored at -80°C. 619 620 Acharya, G. Reginato, E. Cannavo 
